Evidence map›Paper›PMID 35568253›Full record

ArticleJournal of lipid research2022

ω-O-Acylceramides but not ω-hydroxy ceramides are required for healthy lamellar phase architecture of skin barrier lipids.

Lukáš Opálka, Jason M Meyer, Veronika Ondrejčeková, Linda Svatošová, Franz P W Radner, Kateřina Vávrová

Open access · goldAbstract read
In one paragraph

Article in Journal of lipid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Disorders of fatty acid homeostasis.Journal of inherited metabolic disease · 2025
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Lukáš OpálkaCharles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.
Jason M MeyerDepartment of Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA.
Veronika OndrejčekováCharles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.
Linda SvatošováCharles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.
Franz P W RadnerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Kateřina VávrováCharles University, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic. Electronic address: katerina.vavrova@faf.cuni.cz.
Charles University · CZUniversity of Graz · ATVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermal omega-O-acylceramides (ω-O-acylCers) are essential components of a competent skin barrier. These unusual sphingolipids with ultralong N-acyl chains contain linoleic acid esterified to the terminal hydroxyl of the N-acyl, the formation of which requires the transacylase activity of patatin-like phospholipase domain containing 1 (PNPLA1). In ichthyosis with dysfunctional PNPLA1, ω-O-acylCer levels are significantly decreased, and ω-hydroxylated Cers (ω-OHCers) accumulate. Here, we explore the role of the linoleate moiety in ω-O-acylCers in the assembly of the skin lipid barrier. Ultrastructural studies of skin samples from neonatal Pnpla1

Indexed as

CeramidesSkinAcyltransferasesAnimalsEpidermisIchthyosisLinoleic AcidLipaseMiceAcyltransferasesCeramidesLinoleic AcidLipasePNPLA1 protein, mouseacylceramidesbarrier functionceramideslinoleic acidlipidsmodel membranesPNPLA1 deficiencySkinsphingolipidsstratum corneum

Identifiers

PMID35568253
PMCPMC9192818
OpenAlexW4280512564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.